A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates

• DOI: 10.1073/pnas.0913374107
• Publication Date: 2009-12-29T02:10:18Z
• Authors: Joanna Kubler-Kielb; Fathy Majadly; Zuzana Biesova; Christopher P. Mocca; Chunyan Guo; Ruth Nussenzweig; Victor Nussenzweig; Satish Mishra; Yimin Wu; Louis H. Miller; Jerry M. Keith; Teh-Yung Liu; John B. Robbins; Rachel Schneerson
• Keywords: T-Lymphocytes; Plasmodium falciparum; Protozoan Proteins; Antibodies, Protozoan; Fluorescent Antibody Technique; Enzyme-Linked Immunosorbent Assay; Gas Chromatography-Mass Spectrometry; Recombinant Proteins; 3. Good health; Epitopes; Mice; 03 medical and health sciences; 0302 clinical medicine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Malaria Vaccines; Animals; Female; Peptides

There is yet no licensed vaccine against malaria, a serious human disease affecting mostly children, with an annual death rate of about one million. Plasmodia , the malaria-causing parasites, have two obligatory hosts: mammals or birds, in which they multiply asexually, and mosquitoes with sexual multiplication. The most common and serious type of malaria is caused by Plasmodium falciparum . The circumsporozoite protein (CSP), a major surface antigen of sporozoites, is a protective antigen. A unique feature of P. falciparum CSP is its large central domain composed of over 30 tetrapeptide repeats of Asn-Ala-Asn-Pro (NANP). Several NANP peptide-protein conjugates were tested clinically but elicited a low level of CSP antibodies for a short duration. To provide a CSP-based candidate vaccine, we investigated recombinant CSP and NANP conjugates of various peptide lengths, with different N-terminal amino acids, bound at different ratios to various carrier proteins. Injected into mice, CSP alone and CSP or NANP conjugates induced antibodies with booster responses and were positive by the sporozoite imunofluorescent assay. The use of the mosquito stage P. falciparum ookinete surface protein, Pfs25, cross-linked onto itself as a carrier for NANP, induced in mice high levels of uniquely long-lasting antibodies to both vaccine components with secondary biological activities, that will provide immunity to liver infection by sporozoites and block transmission by mosquitoes.